PMC:7435837 / 11123-11394
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T107","span":{"begin":119,"end":126},"obj":"Body_part"},{"id":"T108","span":{"begin":204,"end":209},"obj":"Body_part"}],"attributes":[{"id":"A107","pred":"fma_id","subj":"T107","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A108","pred":"fma_id","subj":"T108","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"ecombinant vaccination approach could be demonstrated by expressing the receptor-binding domain [46] of SARS-CoV spike protein in an adenovirus. This recombinant adenovirus was administered nasally and T-cells showed a significant immune response towards the expressed sp"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T21","span":{"begin":104,"end":112},"obj":"Disease"}],"attributes":[{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"ecombinant vaccination approach could be demonstrated by expressing the receptor-binding domain [46] of SARS-CoV spike protein in an adenovirus. This recombinant adenovirus was administered nasally and T-cells showed a significant immune response towards the expressed sp"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T144","span":{"begin":202,"end":209},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T145","span":{"begin":217,"end":218},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"ecombinant vaccination approach could be demonstrated by expressing the receptor-binding domain [46] of SARS-CoV spike protein in an adenovirus. This recombinant adenovirus was administered nasally and T-cells showed a significant immune response towards the expressed sp"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T107","span":{"begin":119,"end":126},"obj":"Chemical"}],"attributes":[{"id":"A107","pred":"chebi_id","subj":"T107","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"ecombinant vaccination approach could be demonstrated by expressing the receptor-binding domain [46] of SARS-CoV spike protein in an adenovirus. This recombinant adenovirus was administered nasally and T-cells showed a significant immune response towards the expressed sp"}
LitCovid-PD-GO-BP
{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T14","span":{"begin":231,"end":246},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"ecombinant vaccination approach could be demonstrated by expressing the receptor-binding domain [46] of SARS-CoV spike protein in an adenovirus. This recombinant adenovirus was administered nasally and T-cells showed a significant immune response towards the expressed sp"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"239","span":{"begin":113,"end":118},"obj":"Gene"},{"id":"243","span":{"begin":104,"end":112},"obj":"Species"},{"id":"244","span":{"begin":133,"end":143},"obj":"Species"},{"id":"245","span":{"begin":162,"end":172},"obj":"Species"}],"attributes":[{"id":"A239","pred":"tao:has_database_id","subj":"239","obj":"Gene:43740568"},{"id":"A243","pred":"tao:has_database_id","subj":"243","obj":"Tax:694009"},{"id":"A244","pred":"tao:has_database_id","subj":"244","obj":"Tax:10508"},{"id":"A245","pred":"tao:has_database_id","subj":"245","obj":"Tax:10508"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ecombinant vaccination approach could be demonstrated by expressing the receptor-binding domain [46] of SARS-CoV spike protein in an adenovirus. This recombinant adenovirus was administered nasally and T-cells showed a significant immune response towards the expressed sp"}
2_test
{"project":"2_test","denotations":[{"id":"32731428-26935699-71421285","span":{"begin":97,"end":99},"obj":"26935699"}],"text":"ecombinant vaccination approach could be demonstrated by expressing the receptor-binding domain [46] of SARS-CoV spike protein in an adenovirus. This recombinant adenovirus was administered nasally and T-cells showed a significant immune response towards the expressed sp"}